Personalized chemotherapy may favorably alter intrinsic disease biology to produce a higher proportion of long term survivors in patients with advanced NSCLC
Simon GR, Kim J, Schell M, Bepler G
Personalized chemotherapy may favorably alter intrinsic disease biology to produce a higher proportion of long term survivors in patients with advanced NSCLC
Journal of Thoracic Oncology. 2009 Sep;4(9):S403-S403.